[Activity Report] Submission of recommendations to Public Comment on the “Draft Order of the Pandemic Influenza and New Infection Diseases Preparedness and Response Council”
date : 3/25/2021
Tags: AMR
On March 25, 2021, the Health and Global Policy Institute submitted its opinions to a public comment on the “Draft Order of the Pandemic Influenza and New Infection Diseases Preparedness and Response Council.”
A summary of the comments is as follows. Please see the PDF file found here for details (information available only in Japanese).
Antimicrobial resistance (AMR) occurs when the organisms that cause infectious diseases grow resistant to treatment. This problem can lead to otherwise preventable deaths due to infectious diseases. It is estimated that 8,000 people die annually from AMR-related causes in Japan, which is more than twice the number of annual traffic deaths. This number is comparable to the 8,835 deaths caused by COVID-19 so far in Japan (as of March 22, 2021).
Bold policies on AMR are urgently needed to prevent the loss of countless lives in the future. Based on the strong leadership of the government, Japan enacted a National Action Plan on Antimicrobial Resistance in April 2016, which greatly contributed to the promotion of AMR measures domestically. Even though it is about time for the next action plan to be announced, there is no clear date for its release despite the many existing issues related to AMR.
The COVID-19 pandemic has shown just how important it is to prepare for infectious disease problems ahead of time. AMR too is an infectious disease crisis. A Subcommittee on AMR should be established within the Government to consider AMR measures including the formulation of the next action plan.
日本語
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Alliance for Transformative Action on Climate and Health (April 22, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] (Webinar) The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-30
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Community Development for Senior Health: From Establishing Evidence to Social Implementation” (April 23, 2024)
-
2024-05-02
[Event Report] The 123rd HGPI Seminar – The Current Situation and Future Prospects for Epilepsy in Japan and Around the World (March 6, 2024)
-
2024-05-09
[Registration Open] The Health Policy Academy the 13th Session